Abstract:CCN family member 2 (CCN2), also known as connective tissue growth factor (CTGF), has been suggested to be an endochondral ossification genetic factor that has been termed "ecogenin", because in vitro studies revealed that CCN2 promotes the proliferation and differentiation of growth-plate chondrocytes, osteoblasts, and vascular endothelial cells, all of which play important roles in endochondral ossification. In addition to its action toward these three types of cells, CCN2 was recently found to promote the formation of osteoclasts in vitro, which cells play an important role in the replacement of cartilage by bone during endochondral ossification, thus strengthening the "ecogenin" hypothesis. For confirmation of this hypothesis, transgenic mice over-expressing CCN2 in cartilage were generated. The results proved the hypothesis; i.e., the over-expression of CCN2 in cartilage stimulated the proliferation and differentiation of growth-plate chondrocytes, resulting in the promotion of endochondral ossification. In addition to its "ecogenin" action, CCN2 had earlier been shown to promote the differentiation of various cartilage cells including articular cartilage cells. In accordance with these findings, cartilage-specific overexpression of CCN2 in the transgenic mice was shown to protect against the development of osteoarthritic changes in aging articular cartilage. Thus, CCN2 may also play a role as an anti-aging (chondroprotective) factor, stabilizing articular cartilage. CCN2 also had been shown to promote intramembranous ossification, regenerate cartilage and bone, and induce angiogenesis in vivo. For understanding of the molecular mechanism underlying such multifunctional actions, yeast two-hybrid analysis, protein array analysis, solid-phase binding assay, and surface plasmon resonance (SPR) analysis have been used to search for binding partners of CCN2. ECMs such as fibronectin and aggrecan, growth factors including BMPs and FGF2 and their receptors such as FGFR1 and 2 and RANK, as well as CCN family members themselves, were shown to bind to CCN2. Regarding the interaction of CCN2 with some of them, various binding modules in the CCN2 molecule have been identified. Therefore, the numerous biological actions of CCN2 would depend on what kinds of binding partners and what levels of them are present in the microenvironment of different types of cells, as well as on the state of differentiation of these cells. Through this mechanism, CCN2 would orchestrate various signaling pathways, acting as a signal conductor to promote harmonized skeletal growth and regeneration.

Connective tissue growth factor (CCN2) inhibits TNF--induced apoptosis by enhancing autophagy through the Akt and Erk pathways in osteoblasts

Autophagy was involved in tumor necrosis factor--inhibited osteogenic differentiation of murine calvarial osteoblasts through Wnt/-catenin pathway

Autophagy was involved in tumor necrosis factor-α-inhibited osteogenic differentiation of murine calvarial osteoblasts through Wnt/β-catenin pathway.

The Matricellular Protein CCN1 Regulates TNF‐α Induced Vascular Endothelial Cell Apoptosis

Inhibition of JAK2 by AG490 promotes TNF--induced apoptosis by inhibiting autophagy in MC3T3-E1 cells

Role of autophagy in tumor necrosis factor-α-induced apoptosis of osteoblast cells

Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinoma

CCN2: a master regulator of the genesis of bone and cartilage

TNF Antagonizes CCN1 in Apoptosis in Esophageal Adenocarcinoma.

Effects of Connective Tissue Growth Factor (CTGF/CCN2) on Condylar Chondrocyte Proliferation, Migration, Maturation, Differentiation and Signalling Pathway

CCN1 induces oncostatin M production in osteoblasts via integrin-dependent signal pathways

Undercarboxylated, But Not Carboxylated, Osteocalcin Suppresses TNF-α-Induced Inflammatory Signaling Pathway in Myoblasts

NOV/CCN3 induces cartilage protection by inhibiting PI3K/AKT/mTOR pathway

Low concentrations of tumor necrosis factor-alpha promote human periodontal ligament stem cells osteogenic differentiation by activation of autophagy via inhibition of AKT/mTOR pathway

Low concentrations of TNF-α promote osteogenic differentiation via activation of the ephrinB2-EphB4 signalling pathway.

Connective Tissue Growth Factor and Renal Fibrosis.

EphB4/ TNFR2/ERK/MAPK Signaling Pathway Comprises a Signaling Axis to Mediate the Positive Effect of TNF-α on Osteogenic Differentiation

Necroptosis Occurs in Osteoblasts During Tumor Necrosis Factor-Α Stimulation and Caspase-8 Inhibition

Suppression of Tumor Necrosis Factor-mediated Apoptosis by Nuclear Factor Κb-Independent Bone Morphogenetic Protein/Smad Signaling

Osteogenesis Is Improved by Low Tumor Necrosis Factor Alpha Concentration through the Modulation of Gs-Coupled Receptor Signals

Cellular communication network factor 1 interlinks autophagy and ERK signaling to promote osteogenesis of periodontal ligament stem cells